We are live on ! Find out more
DWM

Doyle Wealth Management Portfolio holdings

AUM $1.16B
1-Year Est. Return 9.32%
This Fund
S&P 500
This Quarter Est. Return
+0.67%
1 Year Est. Return
-9.32%
3 Year Est. Return
+32.31%
5 Year Est. Return
+58.61%
10 Year Est. Return
AUM
$1.26B
AUM Growth
+$52.1M
Cap. Flow
+$48.1M
Cap. Flow %
3.82%
Top 10 Hldgs %
28.76%
Holding
228
New
9
Increased
127
Reduced
50
Closed
5

Top Sells

Rank Stock Value
1
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$2.71M
2
KMB icon
Kimberly-Clark
KMB
+$1.69M
3
AAPL icon
Apple
AAPL
+$1.57M
4
T icon
AT&T
T
+$1.54M
5
OGN icon
Organon & Co
OGN
+$520K

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.81%
2 Technology 20.8%
3 Financials 12.71%
4 Healthcare 11.18%
5 Consumer Discretionary 8.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELV icon
151
Elevance Health
ELV
$85.5B
$417K 0.03%
1,120
+1
+0.1% +$380
CL icon
152
Colgate-Palmolive
CL
$72.3B
$411K 0.03%
5,440
-271
-5% -$21.5K
BAX icon
153
Baxter International
BAX
$13.5B
$410K 0.03%
5,103
-458
-8% -$36.2K
VLY icon
154
Valley National Bancorp
VLY
$7.69B
$409K 0.03%
30,710
TFC icon
155
Truist Financial
TFC
$61.6B
$408K 0.03%
6,951
-351
-5% -$19.6K
SCL icon
156
Stepan Co
SCL
$1.42B
$407K 0.03%
3,600
ETN icon
157
Eaton
ETN
$156B
$399K 0.03%
2,670
-997
-27% -$159K
IRDM icon
158
Iridium Communications
IRDM
$4.94B
$399K 0.03%
+10,000
New +$420K
AMD icon
159
Advanced Micro Devices
AMD
$760B
$394K 0.03%
3,831
AZN icon
160
AstraZeneca
AZN
$252B
$390K 0.03%
3,249
-61
-2% -$7.1K
VONG icon
161
Vanguard Russell 1000 Growth ETF
VONG
$45.1B
$390K 0.03%
5,536
+36
+0.7% +$2.62K
MPC icon
162
Marathon Petroleum
MPC
$104B
$389K 0.03%
+6,293
New +$362K
JBLU icon
163
JetBlue
JBLU
$1.81B
$387K 0.03%
25,342
CMI icon
164
Cummins
CMI
$77.8B
$374K 0.03%
1,667
ORCL icon
165
Oracle
ORCL
$435B
$368K 0.03%
4,220
+616
+17% +$54.4K
VTEB icon
166
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.6B
$365K 0.03%
6,656
+1,367
+26% +$75.6K
IJR icon
167
iShares Core S&P Small-Cap ETF
IJR
$110B
$364K 0.03%
3,329
+175
+6% +$19.3K
EMN icon
168
Eastman Chemical
EMN
$8.35B
$363K 0.03%
3,601
-750
-17% -$82.8K
MAA icon
169
Mid-America Apartment Communities
MAA
$15B
$354K 0.03%
1,893
DISCK
170
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$349K 0.03%
14,367
ARCC icon
171
Ares Capital
ARCC
$14.3B
$336K 0.03%
16,526
INGR icon
172
Ingredion
INGR
$6.6B
$331K 0.03%
3,716
+15
+0.4% +$1.32K
VT icon
173
Vanguard Total World Stock ETF
VT
$81.2B
$329K 0.03%
3,231
+65
+2% +$6.81K
STZ icon
174
Constellation Brands
STZ
$22.3B
$327K 0.03%
1,554
+2
+0.1% +$437
TRV icon
175
Travelers Companies
TRV
$77.2B
$327K 0.03%
2,151

Similar funds

Doyle Wealth Management's Q3 2021 Portfolio in Review

As of Q3 2021, Doyle Wealth Management held 228 positions worth $1.26B, up 4.3% from $1.21B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Doyle Wealth Management deployed $48.1M of net new capital in Q3 2021, opening 9 new positions and adding to 127 existing holdings. Its largest new stake was Aflac: 10,223 shares worth $533K.

By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $2.71M trimmed.

  • Doyle Wealth Management's largest Q3 2021 buy was Aflac: 10,223 shares worth $533K.
  • Doyle Wealth Management added most to Vanguard Short-Term Corporate Bond ETF in Q3 2021, an estimated $6.66M increase.
  • Doyle Wealth Management's biggest Q3 2021 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $2.71M.
  • Doyle Wealth Management fully exited Organon & Co in Q3 2021, selling an estimated $520K.
  • Doyle Wealth Management's ten largest holdings make up 29% of its $1.26B portfolio in Q3 2021.
  • Doyle Wealth Management opened 9 new positions and closed 5 in Q3 2021.
  • Doyle Wealth Management's portfolio value rose 4.3% quarter-over-quarter to $1.26B.

Based on Doyle Wealth Management's 13F filing for Q3 2021, filed 12 Nov 2021.